The European Centre for Disease Prevention and Control has received information about an increase in cases of acute hepatitis in children in recent weeks in the United Kingdom (UK) and is sharing it internationally to raise awareness among doctors caring for children, in order to determine whether there are similar cases in other countries. In […]
Read More
7th April: World Health Day
World Health Day, established in 1948 by the First World Health Assembly in honour of the founding of the World Health Organization (WHO), is celebrated today, 7 April. This year’s theme for 2022 is “Our Planet, Our Health”, in which the WHO, in addition to continuing to prioritise the importance of the COVID-19, will focus […]
Read More
Health Council Meeting – Main results – 29 March 2022
After discussing the EU’s response to the impact of the war in Ukraine on public health, ministers exchanged views on the challenges that lie ahead for the EU’s vaccine strategy. Health and humanitarian situation in Ukraine The Commission informed delegations about the public health and humanitarian situation in Ukraine and the steps taken by the […]
Read More
COVID-19 Patients in Hospitals and Vaccination and in Europe
EMA starts rolling review of COVID-19 Vaccine HIPRA EMA’s human medicines committee (CHMP) has started a rolling review of COVID-19 Vaccine HIPRA (also known as PHH-1V). This protein-based vaccine is being developed by HIPRA Human Health S.L.U. as a booster vaccine for adults who have already been fully vaccinated with a different COVID-19 vaccine. The CHMP’s […]
Read More
Negotiations for the international treaty on pandemics
The Council adopted a decision to authorise the opening of negotiations for an international agreement on pandemic prevention, preparedness and response. The decision also clears the way for negotiating complementary amendments to the International Health Regulations. The decision authorises the Commission, for matters falling within Union competence, to negotiate an international agreement on pandemic prevention, […]
Read More
COVID-19 research and public health, EU priorities
70.9% of adolescents aged 15-17 years and 34.8% of those aged 10-14 years completed the primary course of vaccination against COVID-19, albeit with a wide range among EU/EEA countries. More than half of adolescents aged 10-17 years in the EU/EEA have not yet completed the primary course. Although the risk of hospitalization, ICU admission, and […]
Read More
EU and Spain in the global action plan against COVID-19
In the COVID-19 Global Action Meeting, convened by US Secretary of State Blinken and gathering the EU, represented by Commissioner Urpilainen, and other partner countries, participants discussed yesterday a ‘COVID-19 Global Action Plan’. The objective is to help coordinate actions and mobilise resources in six priority areas in relation to the global COVID-19 response to […]
Read More
Brussels proposes to extend the EU Digital COVID Certificate by one year
As the COVID-19 virus continues to prevail in Europe and at this stage it is not possible to determine the impact of a possible increase in infections in the second half of 2022 or the emergence of new variants, the European Commission has proposed to extend the Digital COVID Certificate until 30 June 2023. The […]
Read More
EU proposes new rules for clinical trials
As of January 31, the evaluation and monitoring processes for clinical trials began to be harmonized throughout the EU, especially through the Clinical Trials Information System, managed by the European Medicines Agency. On this date, the Clinical Trials Regulation will enter into force, which will improve the way clinical trials are conducted in the EU, […]
Read More